During the past decade, Centro de Pesquisas em Diabetes Ltda. conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro de Pesquisas em Diabetes Ltda." #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centro de Pesquisas em Diabetes Ltda." are "Diabetes Mellitus, Type 2" (1 trials), "Diabetes, Type 1" (1 trials), "Dyslipidemia" (1 trials), "Lupus Erythematosus, Systemic" (1 trials) and "Type2 Diabetes" (1 trials). Many other conditions were trialed in "Centro de Pesquisas em Diabetes Ltda." in a lesser frequency.

Most popular intervention types in "Centro de Pesquisas em Diabetes Ltda." are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Atacicept 150 mg" (1 trials), "Atacicept 75 mg" (1 trials), "Insulin glargine" (1 trials), "Insulin lispro" (1 trials) and "K-877" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro de Pesquisas em Diabetes Ltda." are 4 trials for "All" genders.

Currently, there are NaN active trials in "Centro de Pesquisas em Diabetes Ltda.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Centro de Pesquisas em Diabetes Ltda., 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Centro de Pesquisas em Diabetes Ltda., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".